Austria excels in lung cancer treatment, with top institutions like Wiener Privatklinik, Confraternitaet Private Hospital, and Vienna General Hospital (AKH). These clinics have ISO accreditations, ensuring rigorous quality control. Wiener Privatklinik offers stereotactic body radiotherapy, robotic-assisted thoracic surgery, and targeted therapy. Confraternitaet Hospital implements a multi-stage care system for comprehensive treatment.
Vienna General Hospital (AKH), with its 10,000 medical professionals, stands as a leading center in Europe through its network of 42 university hospitals and institutes. AKH provides advanced non-small cell lung cancer treatments including EGFR-targeted therapies that have shown objective response rates of 38.4% with a median duration of response of 10 months according to clinical trial data. Austrian oncology centers continue developing innovative approaches to improve these outcomes, particularly for patients with brain metastases.